Impact of duration of perioperative antibiotic prophylaxis on development of fracture-related infection in open fractures.


Journal

Archives of orthopaedic and trauma surgery
ISSN: 1434-3916
Titre abrégé: Arch Orthop Trauma Surg
Pays: Germany
ID NLM: 9011043

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 27 01 2020
pubmed: 16 5 2020
medline: 29 5 2021
entrez: 16 5 2020
Statut: ppublish

Résumé

Infection is a common complication of open fractures potentially leading to nonunion, functional loss, and even amputation. Perioperative antibiotic prophylaxis (PAP) is standard practice for infection prevention in the management of open fractures. However, optimal duration of PAP remains controversial. The objectives were to assess whether PAP duration is independently associated with infection in open fractures and if administration of PAP beyond the commonly-recommended limit of 72 h has any effect on the infection rate. Over a 14-year period from 2003 to 2017, 530 skeletally-mature patients with operatively-treated, non-pathologic, long-bone open fractures were treated at one institution. Twenty-eight patients were excluded because of death or loss to follow-up and the remaining 502 patients (with 559 open fractures) who completed a 24-month follow-up were included in this retrospective study. The outcome was fracture-related infection (FRI), defined by the criteria of a recent consensus definition. A logistic generalized estimating equations regression model was conducted, including PAP duration and variables selected by a least absolute shrinkage and selection operator (LASSO) method, to assess the association between PAP duration and FRI. Propensity score analysis using a 72-h cut-off was performed to further cope with confounding. PAP duration, adjusted for the LASSO selected predictors, was independently associated with FRI (OR: 1.11 [95%CI, 1.04-1.19] for every one-day increase in PAP duration, p = 0.003). PAP duration longer than 72 h did not significantly increase the odds for FRI compared to shorter durations (p = 0.06, analysis adjusted for propensity score). This study found no evidence that administration of prophylactic antibiotics beyond 72 h in patients with long-bone open fractures is warranted. Analyses adjusted for known confounders even revealed a higher risk for FRI for longer PAP. However, this effect cannot necessarily be considered as causal and further research is needed.

Identifiants

pubmed: 32409906
doi: 10.1007/s00402-020-03474-8
pii: 10.1007/s00402-020-03474-8
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

235-243

Références

Metsemakers WJ, Kuehl R, Moriarty TF, Richards RG, Verhofstad MHJ, Borens O, Kates S, Morgenstern M (2018) Infection after fracture fixation: current surgical and microbiological concepts. Injury 49(3):511–522
doi: 10.1016/j.injury.2016.09.019
Papakostidis C, Kanakaris NK, Pretel J, Faour O, Morell DJ, Giannoudis PV (2011) Prevalence of complications of open tibial shaft fractures stratified as per the Gustilo–Anderson classification. Injury 42(12):1408–1415
doi: 10.1016/j.injury.2011.10.015
Gustilo RB, Anderson JT (1976) Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses. J Bone Jt Surg Am 58(4):453–458
doi: 10.2106/00004623-197658040-00004
Gustilo RB, Mendoza RM, Williams DN (1984) Problems in the management of type III (severe) open fractures: a new classification of type III open fractures. J Trauma 24(8):742–746
doi: 10.1097/00005373-198408000-00009
Dunkel N, Pittet D, Tovmirzaeva L, Suva D, Bernard L, Lew D, Hoffmeyer P, Uckay I: Short duration of antibiotic prophylaxis in open fractures does not enhance risk of subsequent infection. Bone Joint J 2013, 95-b(6):831–837.
Kortram K, Bezstarosti H, Metsemakers WJ, Raschke MJ, Van Lieshout EMM, Verhofstad MHJ (2017) Risk factors for infectious complications after open fractures; a systematic review and meta-analysis. Int Orthop 41(10):1965–1982
doi: 10.1007/s00264-017-3556-5
Zalavras CG (2017) Prevention of infection in open fractures. Infect Dis Clin North Am 31(2):339–352
doi: 10.1016/j.idc.2017.01.005
Zalavras CG, Marcus RE, Levin LS, Patzakis MJ (2007) Management of open fractures and subsequent complications. J Bone Jt Surg Am 89(4):884–895
doi: 10.2106/00004623-200704000-00027
Puetzler J, Zalavras C, Moriarty TF, Verhofstad MHJ, Kates SL, Raschke MJ, Rosslenbroich S, Metsemakers WJ (2019) Clinical practice in prevention of fracture-related infection: an international survey among 1197 orthopaedic trauma surgeons. Injury 50(6):1208–1215
doi: 10.1016/j.injury.2019.04.013
Obremskey W, Molina C, Collinge C, Nana A, Tornetta P 3rd, Sagi C, Schmidt A, Probe R, Ahn J, Browner BD (2014) Current practice in the management of open fractures among orthopaedic trauma surgeons. Part A: initial management. A survey of orthopaedic trauma surgeons. J Orthop Trauma 28(8):e198–202
doi: 10.1097/BOT.0000000000000033
Gumbel D, Matthes G, Napp M, Lange J, Hinz P, Spitzmuller R, Ekkernkamp A (2016) Current management of open fractures: results from an online survey. Arch Orthop Trauma Surg 136(12):1663–1672
doi: 10.1007/s00402-016-2566-x
Dellinger EP, Caplan ES, Weaver LD, Wertz MJ, Droppert BM, Hoyt N, Brumback R, Burgess A, Poka A, Benirschke SK et al (1988) Duration of preventive antibiotic administration for open extremity fractures. Arch Surg 123(3):333–339
doi: 10.1001/archsurg.1988.01400270067010
Carsenti-Etesse H, Doyon F, Desplaces N, Gagey O, Tancrede C, Pradier C, Dunais B, Dellamonica P (1999) Epidemiology of bacterial infection during management of open leg fractures. Eur J Clin Microbiol Infect Dis 18(5):315–323
doi: 10.1007/PL00015012
Chang Y, Bhandari M, Zhu KL, Mirza RD, Ren M, Kennedy SA, Negm A, Bhatnagar N, Naji FN, Milovanovic L et al (2019) Antibiotic prophylaxis in the management of open fractures: a systematic survey of current practice and recommendations. JBJS Rev 7(2):e1
doi: 10.2106/JBJS.RVW.17.00197
Hoff WS, Bonadies JA, Cachecho R, Dorlac WC (2011) East Practice Management Guidelines Work Group: update to practice management guidelines for prophylactic antibiotic use in open fractures. J Trauma 70(3):751–754
doi: 10.1097/TA.0b013e31820930e5
Nanchahal J, Nayagam S, Khan U, Moran C, Barrett S, Sanderson F, Pallisher I (2009) Standards for the management of open fractures of the lower limb. The Royal Society of Medicine Press Ltd, UK
Obremskey WT, Metsemakers WJ, Schlatterer DR, Tetsworth K, Egol K, Kates S, McNally M, Gibbons J, Kenny P, Stangl P et al (2020) Musculoskeletal infection in orthopaedic trauma: assessment of the 2018 international consensus meeting on musculoskeletal infection. J Bone Jt Surg Am (Epub ahead of print)
Messner J, Papakostidis C, Giannoudis PV, Kanakaris NK (2017) Duration of administration of antibiotic agents for open fractures: meta-analysis of the existing evidence. Surg Infect (Larchmt) 18(8):854–867
doi: 10.1089/sur.2017.108
Pape HC, Lefering R, Butcher N, Peitzman A, Leenen L, Marzi I, Lichte P, Josten C, Bouillon B, Schmucker U et al (2014) The definition of polytrauma revisited: an international consensus process and proposal of the new 'Berlin definition'. J Trauma Acute Care Surg 77(5):780–786
doi: 10.1097/TA.0000000000000453
Marsh JL, Slongo TF, Agel J, Broderick JS, Creevey W, DeCoster TA, Prokuski L, Sirkin MS, Ziran B, Henley B et al (2007) Fracture and dislocation classification compendium—2007: orthopaedic trauma association classification, database and outcomes committee. J Orthop Trauma 21(10 Suppl):S1–133
doi: 10.1097/00005131-200711101-00001
Declercq P, Nijs S, D'Hoore A, Van Wijngaerden E, Wolthuis A, de Buck van Overstraeten A, Wauters J, Spriet I (2016) Augmented renal clearance in non-critically ill abdominal and trauma surgery patients is an underestimated phenomenon: a point prevalence study. J Trauma Acute Care Surg 81(3):468–477
doi: 10.1097/TA.0000000000001138
Udy AA, Varghese JM, Altukroni M, Briscoe S, McWhinney BC, Ungerer JP, Lipman J, Roberts JA (2012) Subtherapeutic initial beta-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations. Chest 142(1):30–39
doi: 10.1378/chest.11-1671
Declercq P, Gijsen M, Meijers B, Schetz M, Nijs S, D'Hoore A, Wauters J, Spriet I (2018) Reliability of serum creatinine-based formulae estimating renal function in non-critically ill surgery patients: focus on augmented renal clearance. J Clin Pharm Ther 45(5):695–706
doi: 10.1111/jcpt.12695
Metsemakers WJ, Morgenstern M, McNally MA, Moriarty TF, McFadyen I, Scarborough M, Athanasou NA, Ochsner PE, Kuehl R, Raschke M et al (2018) Fracture-related infection: a consensus on definition from an international expert group. Injury 49(3):505–510
doi: 10.1016/j.injury.2017.08.040
Yuan M, Lin Y (2006) Model selection and estimation in regression with grouped variables. J R Stat Soc Series B (Statistical Methodology) 68(1):49–67
doi: 10.1111/j.1467-9868.2005.00532.x
Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70(1):41–55
doi: 10.1093/biomet/70.1.41
Hauser CJ, Adams CA Jr, Eachempati SR (2006) Surgical Infection Society guideline: prophylactic antibiotic use in open fractures: an evidence-based guideline. Surg Infect (Larchmt) 7(4):379–405
doi: 10.1089/sur.2006.7.379
Patzakis MJ, Harvey JP Jr, Ivler D (1974) The role of antibiotics in the management of open fractures. J Bone Jt Surg Am 56(3):532–541
doi: 10.2106/00004623-197456030-00010
Stennett CA, O'Hara NN, Sprague S, Petrisor B, Jeray KJ, Leekha S, Yimgang DP, Joshi M, O'Toole RV, Bhandari M et al (2020) Effect of extended prophylactic antibiotic duration in the treatment of open fracture wounds differs by level of contamination. J Orthop Trauma 34(3):113–120
doi: 10.1097/BOT.0000000000001715
Gustilo RB (1995) Interobserver agreement in the classification of open fractures of the tibia. The results of a survey of two hundred and forty-five orthopaedic surgeons. J Bone Jt Surg Am 77(8):1291–1292
doi: 10.2106/00004623-199508000-00024

Auteurs

Peter Declercq (P)

Pharmacy Department, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. peter.declercq@uzleuven.be.
Department of Pharmaceutical and Pharmacological Sciences, Clinical Pharmacology and Pharmacotherapy, KU Leuven, University of Leuven, Herestraat 49, 3000, Leuven, Belgium. peter.declercq@uzleuven.be.

Charalampos Zalavras (C)

Department of Orthopaedic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, USA.

André Nijssen (A)

Department of Trauma Surgery, University Hospitals Leuven, 3000, Leuven, Belgium.

Beatrijs Mertens (B)

Department of Pharmaceutical and Pharmacological Sciences, Clinical Pharmacology and Pharmacotherapy, KU Leuven, University of Leuven, Herestraat 49, 3000, Leuven, Belgium.

Julie Mesure (J)

Department of Pharmaceutical and Pharmacological Sciences, Clinical Pharmacology and Pharmacotherapy, KU Leuven, University of Leuven, Herestraat 49, 3000, Leuven, Belgium.

Jorien Quintens (J)

Department of Trauma Surgery, University Hospitals Leuven, 3000, Leuven, Belgium.

Thomas De Ridder (T)

Department of Trauma Surgery, University Hospitals Leuven, 3000, Leuven, Belgium.

Ann Belmans (A)

KU Leuven, L-BioStat, 3000, Leuven, Belgium.

Stefaan Nijs (S)

Department of Trauma Surgery, University Hospitals Leuven, 3000, Leuven, Belgium.
Department of Development and Regeneration, KU Leuven, University of Leuven, 3000, Leuven, Belgium.

Isabel Spriet (I)

Pharmacy Department, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.
Department of Pharmaceutical and Pharmacological Sciences, Clinical Pharmacology and Pharmacotherapy, KU Leuven, University of Leuven, Herestraat 49, 3000, Leuven, Belgium.

Willem-Jan Metsemakers (WJ)

Department of Trauma Surgery, University Hospitals Leuven, 3000, Leuven, Belgium.
Department of Development and Regeneration, KU Leuven, University of Leuven, 3000, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH